Series B Pharmaceutical Companies

MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.

Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.

Technology-driven infusion therapy company

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

Nuevocor operates as a preclinical-stage biotech company.

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

Abrexa Pharmaceuticals is a developer of drugs designed to treat Alzheimer disease.

PhotoPharmics is a medical device company that develops treatments for treating neurodegenerative disorders.

Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Woolsey Pharmaceuticals specializes in reinventing ways to treat some of the world’s most challenging diseases.

Drug candidates with a unique mechanism of action, aiming to reduce inflammation and pain. Vipoglanstat to enter phase II for endometriosis.

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.

XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

Kookmin Bio is a biotechnology company that specialises in the development of bio-food and pharmaceutical materials.

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

Alpha Fusion is a clinical research company that focuses on cancer treatment through the design and development of radiopharmaceuticals.

858 Therapeutics develops small molecule drugs targeting oncology and immunology.